Broadleaf Partners, LLC Dexcom Inc Transaction History

Broadleaf Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$110.31 - $140.45 $55,927 - $71,208	-507 Reduced 0.61%	82,305 $9.33 Million
Q1 2024 May 14, 2024	BUY	$114.22 - $140.1 $115,362 - $141,501	1,010 Added 1.23%	82,812 $11.5 Million
Q4 2023 Feb 13, 2024	SELL	$75.49 - $124.16 $159,283 - $261,977	-2,110 Reduced 2.51%	81,802 $10.2 Million
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $2.12 Million - $3.4 Million	24,642 Added 41.58%	83,912 $7.83 Million
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $6.67 Million - $7.76 Million	59,270 New	59,270 $7.62 Million
Q2 2022 Aug 09, 2022	SELL	$67.99 - $132.89 $561,189 - $1.1 Million	-8,254 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$94.08 - $130.2 $776,536 - $1.07 Million	8,254 New	8,254 $4.22 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Broadleaf Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Broadleaf Partners, LLC with notifications on news.